News Overview

With the Nifty and the Sensex already at the peak, the coming week will be interestingly poised.

Fall in core inflation raises hopes of a Fed rate cut in the first half of 2024.

FPIs are back to buying in equities, as GDP data gives a big boost to FPI flows.

The Nifty and the Sensex got a big boost from the incredibly positive GDP data for Q3-FY24.

As US data gives dovish hints, the real story is in what the Fed members thing about rates.

Higher GDP reading in India and lower PCE inflation in the US were the big macro news.

By investing in a long duration fund, investors can smartly play the expected fall in interest rates.

The settlement agreement opens the door for Yesafili, a planned biosimilar of Eeylea (aflibercept) injection, to be sold in Canada.

The company has initially estimated that it will raise $409 million at a coupon of about 7.1250%.

The stock was trading 9.04% higher at ₹306.25 a share on the NSE at 1:03 pm.